Skip to main content
Premium Trial:

Request an Annual Quote

ChemAxon, Patcore Ink Software Distribution Agreement

Premium

ChemAxon said this week that it has signed an agreement with Patcore that allows it to distribute the Japanese cheminformatics software company's applications globally.

Patcore produces and markets the CRAIS product series — a suite of cheminformatics applications based on ChemAxon's toolkits that cover many research processes such as compound registration, assay management, data browsing, collaborative interfaces, structure design, and controlled substance compliance.

The suite is comprised of Checker, a controlled substances check system; Transformer, which is used to generate ideas for lead optimization; Browser, used for exploring chemical and biological data; a tool for compound registration; and Assay, which is a standardized environment for registering assay results.

The financial details of the agreement were not disclosed.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.